Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 69-73 , 15 April 2010

Brain interstitial fluid TNF-α after subarachnoid hemorrhage

  • Khalid A. Hanafy

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Corresponding Author InformationCorresponding author.
  • ,
  • Bartosz Grobelny

      Affiliations

    • Department of Neurology, Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • Luis Fernandez

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • Pedro Kurtz

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • E.S. Connolly

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Department of Neurology, Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • Stephan A. Mayer

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Department of Neurology, Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • Christian Schindler

      Affiliations

    • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
  • ,
  • Neeraj Badjatia

      Affiliations

    • Division of Critical Care Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    • Department of Neurology, Department of Neurological Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA

Received 24 September 2009 ,Revised 27 November 2009 ,Accepted 22 December 2009.

References 

  1. Dumont AS, D.R. , Chow MM, Lin CL, Calisaneller T, Ley KF, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:133–135
  2. Claassen J, C.J. , Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke. 2002;33:1225–1232
  3. Haley EC, K.N. , Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86:467–474
  4. Pickard JD, M.G. , Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636–642
  5. Vajkoczy P, M.B. , Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103:9–17
  6. Cahill J, C.J. , Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26:1341–1353
  7. Jayaraman T, P.A. , Shin YS, Li X, Mayer J, Chaudhry H, et al. TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag. 2008;4:805–817
  8. Aoki T, K.H. , Shimamura M, Nakagami H, Wakayama K, Moriwaki T, et al. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation. 2007;116:2830–2840
  9. Mathiesen T, E.G. , Ulfarsson E, Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg. 1997;87:215–220
  10. Fassbender K, H.B. , Rossol S, Bertsch T, Schmeck J, Schütt S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70:534–537
  11. Witkowska AM, B.M. , Socha K, Kochanowicz J, Mariak Z, Konopka M. TNF-alpha and sICAM-1 in intracranial aneurismal rupture. Arch Immunol Ther Exp (Warsz). 2009;57:137–140
  12. Gruber A, R.K. , Graninger W, Donner A, Illievich MU, Czech T. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2000;12:297–306
  13. Hijdra A, v.G.J. , Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19:1250–1256
  14. Brouwers PJ, D.D. , Vermeulen M, Lindsay KW, Hasan D, v.G.J. . Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke. 1993;809–814
  15. van Gijn J, H.A. , Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985;355–362
  16. Vermeij FH, H.D. , Vermeulen M, Tanghe HL, van Gijn J. Predictive factors for deterioration from hydrocephalus after subarachnoid hemorrhage. Neurology. 1994;44(10):1851–1855
  17. Bederson JB, C.E.J. , Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025
  18. Badjatia N, S.E. , Prescutti M, Fernandez L, Fernandez A, Buitrago M, et al. Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med. 2009;37:1893–1897
  19. J.R. , ELISA C. Theory and practice. Methods Mol Biol. 1995;1–218
  20. J.H.a.J. Hilbe. Generalized estimation equations. Boca Raton, FL: Chapman and Hall; 2003;
  21. Frijns CJ, F.R. , Algra A, van Mourik JA, van Gijn J, Rinkel GJ. Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome. J Neurol Neurosurg Psychiatry. 2006;77–83
  22. Peltonen S, J.S. , Kaste M, Lassila R. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg. 1997;87:207–214
  23. Suzuki M, K.A. , Otawara Y, Hirashima Y, Takaku A, Ogawa A. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery. 1999;44:487–493
  24. Hirashima Y, N.S. , Endo S, Kuwayama N, Naruse Y, Takaku A. Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res. 1997;22:1249–1255
  25. Adams HP, K.N. , Torner JC, Nibbelink DW, Sahs AL. Early management of aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1981;54:141–145
  26. Bederson JB, G.I. , Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086–1091
  27. Cánovas D, G.A. , Jato M, Rubio F. Non-aneurysmal subarachnoid hemorrhage: 60 cases. Neurologia. 2006;21:704–709
  28. Fukuda T, H.M. , Ito H. Does traumatic subarachnoid hemorrhage caused by diffuse brain injury cause delayed ischemic brain damage? Comparison with subarachnoid hemorrhage caused by ruptured intracranial aneurysms. Neurosurgery. 1998;43:1040–1049
  29. Hui FK, T.L. , Tanaka T, Cawley CM, Zhang YJ. Clinical differences between angiographically negative, diffuse subarachnoid hemorrhage and perimesencephalic subarachnoid hemorrhage. Neurocrit Care. 2009;11:64–70
  30. Kang DH, P.J. , Lee SH, Park SH, Kim YS, Hamm IS. Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis?. J Clin Neurosci. 2009;16:904–908
  31. Shigemori M, T.T. , Hirohata M, Maruiwa H, Kaku N, Kuramoto S. Clinical significance of traumatic subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 1990;30:396–400
  32. Pang D, S.R. , Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: Part 1–3. Neurosurgery. 1986;19:540–573
  33. Xi G, K.R. , Hoff JT. Pathophysiology of brain edema formation. Neurosurg Clin N Am. 2002;13:371–383
  34. Claassen J, B.G. , Kreiter K, Bates J, Du YE, Copeland D, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32:2012–2020
  35. Kramer AH, H.M. , Nathan B, Gress D, Dumont AS, Kassell NF, et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg. 2008;109:199–207
  36. Brierre S, K.R. , Deboisblanc BP. The endocrine system during sepsis. Am J Med Sci. 2004;328:238–247
  37. Claassen J, V.A. , Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832–838
  38. Fontanella M, R.I. , Gallone S, Rubino E, Fenoglio P, Valfrè W, et al. Tumor necrosis factor-alpha gene and cerebral aneurysms. Neurosurgery. 2007;668–672
  39. Jayaraman T, B.V. , Li X, Mayer J, Silane M, Shin YS, et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery. 2005;57:558–564
  40. Jones A, D.R. , Torsney E, Howe F, Dunkley M, Gnaneswaran Y, et al. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms. Circulation. 2009;119(24):3125–3132
  41. M.C . The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol. 2009;9:271–285

PII: S0022-510X(10)00002-X

doi: 10.1016/j.jns.2009.12.023

Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 69-73 , 15 April 2010